Cardiovascular Manifestations in Behçet’s Disease

키워드

참고문헌 (102)

1. Yazici H, "Behçet syndrome : is it one condition?", Clin Rev Allergy Immunol, 43, pp.275~280 (2012)
2. International Study Group for Behçet’s Disease, "Criteria for diagnosis of Behçet’s disease", Lancet, 335, pp.1078~1080 (1990)
3. International Team for the Revision of the International Criteria for Behçet’s Disease(ITR-ICBD), "The International Criteria for Behçet’s Disease(ICBD) : a collaborative study of 27 countries on the sensitivity and specificity of the new criteria", J Eur Acad Dermatol Venereol, 28, pp.338~347 (2014)
4. Wu X, "Behçet’s disease complicated with thrombosis : a report of 93 Chinese cases", Medicine(Baltimore), 93, pp.e263~ (2014)
5. Alibaz-Oner F, "Behçet disease with vascular involvement : effects of different therapeutic regimens on the incidence of new relapses", Medicine(Baltimore), 94, pp.e494~ (2015)
6. Seyahi E, "Behçet’s disease : how to diagnose and treat vascular involvement", Best Pract Res Clin Rheumatol, 30, pp.279~295 (2016)
7. Ko GY, "The vascular manifestations of Behçet’s disease : angiographic and CT findings", Br J Radiol, 73, pp.1270~1274 (2000)
8. Düzgün N, "Characteristics of vascular involvement in Behçet’s disease", Scand J Rheumatol, 35, pp.65~68 (2006)
9. Seyahi E, "Behçet’s syndrome and thrombosis", Mediterr J Hematol Infect Dis, 3, pp.e2011026~ (2011)
10. Lee I, "Cardiac Behçet disease presenting as aortic valvulitis", aortitis or right heart inflammatory mass : a clinicopathologic study of 12 cases, 2008, pp.32, 390~398
11. Sacré K, "Unusual cardiovascular events in Behçet’s disease", Clin Exp Rheumatol, 28(4Suppl 60), pp.S82~S85 (2010)
12. Geri G, "Spectrum of cardiac lesions in Behçet disease : a series of 52 patients and review of the literature", Medicine(Baltimore), 91, pp.25~34 (2012)
13. Tascilar K, "Vascular involvement in Behçet’s syndrome : a retrospective analysis of associations and the time course", Rheumatology(Oxford), 53, pp.2018~2022 (2014)
14. Wang Y, "Risk factors of cardiovascular involvement in patients with Behcet’s disease", J Transl Autoimmun, 6, pp.100195~ (2023)
15. Alpsoy E, "Behçet disease : an update for dermatologists", Am J Clin Dermatol, 22, pp.477~502 (2021)
16. Emmi G, "Behçet’s syndrome pathophysiology and potential therapeutic targets", Intern Emerg Med, 9, pp.257~265 (2014)
17. de Menthon M, "HLA-B51", B5 and the risk of Behçet’s disease : a systematic review and meta-analysis of case-control genetic association studies, 2009, pp.61, 1287~1296
18. Remmers EF, "Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet’s disease", Nat Genet, 42, pp.698~702 (2010)
19. Mizuki N, "Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet’s disease susceptibility loci", Nat Genet, 42, pp.703~706 (2010)
20. Kirino Y, "Genome-wide association analysis identifies new susceptibility loci for Behçet’s disease and epistasis between HLA-B*51 and ERAP1", Nat Genet, 45, pp.202~207 (2013)
21. Kaneko F, "The role of streptococcal hypersensitivity in the pathogenesis of Behçet’s disease", Eur J Dermatol, 18, pp.489~498 (2008)
22. Lee S, "Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet’s disease", Arch Dermatol Res, 288, pp.179~183 (1996)
23. Consolandi C, "Behçet’s syndrome patients exhibit specific microbiome signature", Autoimmun Rev, 14, pp.269~276 (2015)
24. Emmi G, "Behçet’s syndrome as a model of thrombo-inflammation : the role of neutrophils", Front Immunol, 10, pp.1085~ (2019)
25. Yamaguchi Y, "Natural killer cells control a T-helper 1 response in patients with Behçet’s disease", Arthritis Res Ther, 12, pp.R80~ (2010)
26. Emmi G, "Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease", Medicine(Baltimore), 95, pp.e5516~ (2016)
27. Leiba M, "Thrombophilic factors are not the leading cause of thrombosis in Behçet’s disease", Ann Rheum Dis, 63, pp.1445~1449 (2004)
28. Calamia KT, "Major vessel involvement in Behçet’s disease : an update", Curr Opin Rheumatol, 23, pp.24~31 (2011)
29. Aksu K, "Inflammation-induced thrombosis : mechanisms, disease associations and management", Curr Pharm Des, 18, pp.1478~1493 (2012)
30. Emmi G, "Thrombosis in vasculitis : from pathogenesis to treatment", Thromb J, 13, pp.15~ (2015)
31. Le Joncour A, "Neutrophil, NETs and Behçet’s disease : a review", Clin Immunol, 250, pp.109318~ (2023)
32. Kawakami T, "Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active Behçet disease : implication in neutrophil apoptosis dysfunction", Arch Dermatol, 140, pp.570~574 (2004)
33. Ergun T, "The histopathology of pathergy : a chronologic study of skin hyperreactivity in Behçet’s disease", Int J Dermatol, 37, pp.929~933 (1998)
34. McDonald DR, "Behcet’s disease", CMAJ, 176, pp.1273~1274 (2007)
35. Boyd SR, "Immunopathology of the noninfectious posterior and intermediate uveitides", Surv Ophthalmol, 46, pp.209~233 (2001)
36. Hirohata S, "Histopathology of the ruptured pulmonary artery aneurysm in a patient with Behçet’s disease", Clin Exp Rheumatol, 27(2 Suppl 53), pp.S91~S95 (2009)
37. Bettiol A, "Vascular Behçet syndrome : from pathogenesis to treatment", Nat Rev Rheumatol, 19, pp.111~126 (2023)
38. Chae EJ, "Radiologic and clinical findings of Behçet disease : comprehensive review of multisystemic involvement", Radiographics, 28, pp.e31~ (2008)
39. Sakane T, "Behçet’s disease", N Engl J Med, 341, pp.1284~1291 (1999)
40. Jennette JC, "2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides", Arthritis Rheum, 65, pp.1~11 (2013)
41. Emmi G, "Vascular Behçet’s syndrome : an update", Intern Emerg Med, 14, pp.645~652 (2019)
42. Nasr H, "Superficial thrombophlebitis(superficial venous thrombosis)", BMJ, 350, pp.h2039~ (2015)
43. Leiba M, "Behçet’s disease and thrombophilia", Ann Rheum Dis, 60, pp.1081~1085 (2001)
44. Farrell JJ, "Incidence and interventions for post-thrombotic syndrome", Cardiovasc Diagn Ther, 6, pp.623~631 (2016)
45. Sarr SA, "Superior vena cava syndrome revealing a Behçet’s disease", Thromb J, 13, pp.7~ (2015)
46. Seyahi E, "Clinical and ultrasonographic evaluation of lower-extremity vein thrombosis in Behcet syndrome: an observational study", Medicine(Baltimore), 94, pp.e1899~ (2015)
47. Seyahi E, "An outcome survey of 43 patients with Budd-Chiari syndrome due to Behçet’s syndrome followed up at a single, dedicated center", Semin Arthritis Rheum, 44, pp.602~609 (2015)
48. Aydinli M, "Budd-Chiari syndrome : etiology, pathogenesis and diagnosis", World J Gastroenterol, 13, pp.2693~2696 (2007)
49. Desbois AC, "Behcet’s disease in Budd-Chiari syndrome", Orphanet J Rare Dis, 9, pp.104~ (2014)
50. Korkmaz C, "Budd-Chiari syndrome in the course of Behcet’s disease : clinical and laboratory analysis of four cases", Joint Bone Spine, 74, pp.245~248 (2007)
51. Lakhanpal S, "Pathologic features of Behçet’s syndrome : a review of Japanese autopsy registry data", Hum Pathol, 16, pp.790~795 (1985)
52. Tüzün H, "Management of aneurysms in Behçet’s syndrome : an analysis of 24 patients", Surgery, 121, pp.150~156 (1997)
53. Tuzun H, "Management and prognosis of nonpulmonary large arterial disease in patients with Behçet disease", J Vasc Surg, 55, pp.157~163 (2012)
54. Saadoun D, "Long-term outcome of arterial lesions in Behçet disease : a series of 101 patients", Medicine(Baltimore), 91, pp.18~24 (2012)
55. Saadoun D, "Mortality in Behçet’s disease", Arthritis Rheum, 62, pp.2806~2812 (2010)
56. Hiller N, "Thoracic manifestations of Behçet disease at CT", Radiographics, 24, pp.801~808 (2004)
57. Bilgin G, "Systemic and pulmonary screening of patients with Behçet’s disease during periodic follow-up", Respir Med, 107, pp.466~471 (2013)
58. Hamuryudan V, "Pulmonary artery involvement in Behçet’s syndrome : effects of anti-Tnf treatment", Semin Arthritis Rheum, 45, pp.369~373 (2015)
59. Yilmaz S, "Pulmonary artery aneurysms in Behçet’s disease", Rheumatol Int, 30, pp.1401~1403 (2010)
60. Raz I, "Pulmonary manifestations in Behçet’s syndrome", Chest, 95, pp.585~589 (1989)
61. Seyahi E, "Pulmonary artery involvement and associated lung disease in Behçet disease : a series of 47 patients", Medicine(Baltimore), 91, pp.35~48 (2012)
62. Erkan D, "Is Hughes-Stovin syndrome Behçet’s disease?", Clin Exp Rheumatol, 22(4 Suppl 34), pp.S64~S68 (2004)
63. Yue C, "Cardiac mass in Behçet’s disease", Clin Exp Rheumatol, 30(3 Suppl 72), pp.S27~S31 (2012)
64. Vayá A, "Intracardiac thrombosis in a case of Behcet’s disease associated with the prothrombin 20210G-A mutation", Haematologica, 85, pp.425~428 (2000)
65. Mogulkoc N, "Intracardiac thrombus in Behçet’s disease : a systematic review", Chest, 118, pp.479~487 (2000)
66. Düzgün N, "Behçet’s disease and intracardiac thrombosis : a report of three cases", Case Rep Rheumatol, 2013, pp.637015~ (2013)
67. Kaya A, "Behçet’s disease with right ventricle thrombus and bilateral pulmonary artery aneurysms--a case report", Angiology, 55, pp.573~575 (2004)
68. Hammami R, "Intracardiac thrombus in a young man: don’t forget Behçet’s disease!", Intern Med, 51, pp.1865~1867 (2012)
69. Kajiya T, "Intracardiac thrombus, superior vena cava syndrome, and pulmonary embolism in a patient with Behçet’s disease : a case report and literature review", Heart Vessels, 22, pp.278~283 (2007)
70. Tang C, "Surgical treatment of Behcet’s disease with severe aortic regurgitation", Front Cardiovasc Med, 10, pp.1290615~ (2023)
71. Og˘uzhan A, "Multiple vascular aneurysms in Behcet’s disease", Anadolu Kardiyol Derg, 5, pp.154~ (2005)
72. Lee S, "Acute myocardial infarction due to an unruptured sinus of Valsalva aneurysm in a patient with Behçet’s syndrome", Yonsei Med J, 48, pp.883~885 (2007)
73. Yoshikawa K, "Aortic root replacement in Behçet disease", Asian Cardiovasc Thorac Ann, 15, pp.521~523 (2007)
74. Gürgün C, "Cardiovascular involvement in Behçet’s disease", Jpn Heart J, 43, pp.389~398 (2002)
75. Ozkan M, "M-mode, 2-D and Doppler echocardiographic study in 65patients with Behçet’s syndrome", Eur Heart J, 13, pp.638~641 (1992)
76. Kusuyama T, "Unruptured aneurysm of the sinus of Valsalva with Behçet’s disease", Circ J, 66, pp.107~108 (2002)
77. Vural U, "Coronary involvement in Behçet’s disease : what are its risks and prognosis?(rare cases and literature review)", Braz J Cardiovasc Surg, 34, pp.749~758 (2019)
78. Fei Y, "Major vascular involvement in Behçet’s disease : a retrospective study of 796 patients", Clin Rheumatol, 32, pp.845~852 (2013)
79. Hatemi G, "2018 update of the EULAR recommendations for the management of Behçet’s syndrome", Ann Rheum Dis, 77, pp.808~818 (2018)
80. Vitale A, "New therapeutic solutions for Behçet’s syndrome", Expert Opin Investig Drugs, 25, pp.827~840 (2016)
81. Ahn JK, "Treatment of venous thrombosis associated with Behcet’s disease : immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation", Clin Rheumatol, 27, pp.201~205 (2008)
82. Gurcan M, "Long term follow-up of Behçet’s syndrome patients treated with cyclophosphamide", Rheumatology(Oxford), 59, pp.2264~2271 (2020)
83. Emmi G, "Adalimumab-based treatment versus disease-modifying antirheumatic drugs for venous thrombosis in Behçet’s syndrome : a retrospective study of seventy patients with vascular involvement", Arthritis Rheumatol, 70, pp.1500~1507 (2018)
84. Seyahi E, "Infliximab in the treatment of hepatic vein thrombosis(Budd-Chiari syndrome)in three patients with Behcet’s syndrome", Rheumatology(Oxford), 46, pp.1213~1214 (2007)
85. Balcioglu O, "Endovascular repair and adjunctive immunosuppressive therapy of aortic involvement in Behçet’s disease", Eur J Vasc Endovasc Surg, 50, pp.593~598 (2015)
86. Koo BK, "Endovascular therapy combined with immunosuppressive treatment for pseudoaneurysms in patients with Behçet’s disease", J Endovasc Ther, 10, pp.75~80 (2003)
87. Zhang X, "Pulmonary involvement in patients with Behçet’s disease : report of 15 cases", Clin Respir J, 9, pp.414~422 (2015)
88. Rossi GM, "Hemoptysis in Behçet’s syndrome : from bedside to bench?", Intern Emerg Med, 13, pp.467~469 (2018)
89. Voiriot G, "Transcatheter embolotherapy of pulmonary artery aneurysms as emergency treatment of hemoptysis in Behcet patients : experience of a referral center and a review of the literature", Intern Emerg Med, 13, pp.491~500 (2018)
90. Hamuryudan V, "Pulmonary artery aneurysms in Behçet syndrome", Am J Med, 117, pp.867~870 (2004)
91. Hamuryudan V, "Pulmonary arterial aneurysms in Behçet’s syndrome : a report of 24 cases", Br J Rheumatol, 33, pp.48~51 (1994)
92. Uzun O, "Pulmonary involvement in Behçet’s disease", Respiration, 75, pp.310~321 (2008)
93. Ianniello A, "Endovascular treatment of a ruptured pulmonary artery aneurysm in a patient with Behçet’s disease using the Amplatzer Vascular Plug 4", Korean J Radiol, 14, pp.283~286 (2013)
94. Cantasdemir M, "Emergency endovascular management of pulmonary artery aneurysms in Behçet’s disease : report of two cases and a review of the literature", Cardiovasc Intervent Radiol, 25, pp.533~537 (2002)
95. Farouk H, "Behçet’s disease, echocardiographers, and cardiac surgeons : together is better", Echocardiography, 31, pp.783~787 (2014)
96. Ben Ghorbel I, "Intracardiac thrombus in Behçet’s disease", Reumatismo, 68, pp.148~153 (2016)
97. Wang H, "Intracardiac thrombus in patients with Behcet’s disease : clinical correlates, imaging features, and outcome : a retrospective, single-center experience", Clin Rheumatol, 35, pp.2501~2507 (2016)
98. Ando M, "Surgical treatment of Behçet’s disease involving aortic regurgitation", Ann Thorac Surg, 68, pp.2136~2140 (1999)
99. Lellouche N, "Recurrent valvular replacement due to exacerbation of Behcet’s disease by Streptococcus agalactiae infection", Eur J Intern Med, 14, pp.120~122 (2003)
100. Guo X, "Preoperative immunosuppressive therapy reduces paravalvular leakage after aortic valve surgery in patients with aortic regurgitation attributable to Behçet’s disease", Clin Exp Rheumatol, 34(6 Suppl 102), pp.S26~S33 (2016)
101. Li X, "Prognostic analysis of Behçet’s disease with aortic regurgitation or involvement", Neth Heart J, 30, pp.172~180 (2022)
102. Choi HM, "Predictors of paravalvular aortic regurgitation after surgery for Behcet’s disease-related severe aortic regurgitation", Orphanet J Rare Dis, 14, pp.132~ (2019)

관련 논문AI추천